Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 807-810

  Bourgeois, C ^a   Bour, J B ^a   Aho, L S ^b   Pothier, P ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RS 348; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 3; CONTROLLED STUDY; DRUG EFFICACY; INFECTION PREVENTION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INHIBITION; VIRUS NEUTRALIZATION;

EID: 0031964794     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.807-810.1998     Document Type: Article

References (25)

1. Arbiza, J., G. Taylor, J. A. Lopez, J. Furze, S. Wyld, P. Whyte, E. J. Stoot, G. Wertz, G. Sullender, M. Trudel, and J. A. Melero. 1992. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 73:2225-2234.
2. Bourgeois, C., C. Corvaisier, J. B. Bour, E. Kohli, and P. Pothier. 1991. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus. J. Gen. Virol. 72:1051-1058.
3. Chothia, C., and A. M. Lesk. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196:901-907
4. Crowe, J. E., Jr., B. R. Murphy, R. M. Chanock, R. A. Williamson, C. F. Barbas III, and D. R. Burton. 1994. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. USA 91:1386-1390.
5. Graham, B. S., Y. W. Tang, and W. C. Gruber. 1995. Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin. J. Infect. Dis. 171:1468-1474.
6. Groothuis, J. R., E. A. F. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, D. A. Tristam, G. R. Siber, G. A. Prince, M. Van Raden, and V. G. Hemming. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N. Engl. J. Med. 329:1324-1530.
7. Groothuis, J. R., E. A. F. Simoes, V. G. Hemming, and the Respiratory Syncytial Virus Immune Globulin Study Group. 1995. Respiratory syncytial (RSV) infection in preterm infants and the protective eftects of RSV immune globulin (RSVIG). Pediatrics 85:463-467.
8. Hemming, V. G., W. Rodriguez, H. W. Kim, C. D. Brandt, R. H. Parrott, B. Burch, G. A. Prince, P. A. Baron, R. J. Fink, and G. Reaman. 1987. Intiavenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob. Agents Chemother. 31:1882-1886.
9. Kabat, E. A., T. T. Wu, H. M. Perry, K. S. Gottesman, and C. Foeller. 1991. Sequences of proteins of immunological interest, publication no. 91-3242. National Institutes of Health, Bethesda, Md.
10. Lamprecht, C. L., H. E. Krause, and M. A. Mufson. 1976. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J. Infect. Dis. 134:211-217.
11. Levi, M., M. Sällberg, U. Ruden, D. Herlyn, H. Maruyama, H. Wigzell, J. Marks, and B. Wahren. 1993. A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 90:4374-4378.
12. Mazanec, M. B., M. E. Lamm, D. Lyn, A. Portner, and J. G. Nedrud. 1992. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 23:1-12.
13. McIntosh, K., H. B. Masters, L. Orr, R. K. Chao, and R. M. Barkin. 1978. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 138:24-32.
14. Piazza, F. M., S. A. Johnson, M. G. Ottolini, H. J. Smidt, M. E. R. Darnell, V. G. Hemming, and G. A. Prince. 1992. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol. J. Infect. Dis. 166:1422-1424.
15. Prince, G. A., R. L. Horswood, E. Camargo, D. Koenig, and R. M. Chanock. 1985. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection of cotton rats. Virus Res. 3:193-206.
16. Prince, G. A., V. G. Hemming, R. L. Horswood, P. A. Baron, and R. M. Chanock. 1987. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J. Virol. 61:1851-1854.
17. Taub, R., R. J. Gould, V. M. Garsky, T. M. Ciccarone, J. Hoxie, P. A. Friedman, and S. J. Shattil. 1989. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor domain in fibrinogen. J. Biol. Chem. 264:259-265.
18. Taylor, G., E. J. Stott, M. Bew, B. F. Fernie, P. J. Cote, A. P. Collins, M. Hugues, and J. Jerbett. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.
19. Taylor, G., J. M. Furze, P. R. Tempest, P. Bremner, F. J. Carr, and W. J. Harris. 1991. Humanised monoclonal antibody to respiratory syncytial virus. Lancet 337:1411-1412.
20. Walsh, E. E., J. J. Schlesinger, and M. W. Brandriss. 1984. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect. Immun. 43:756-758.
21. Walsh, E. E., K. M. McConnochie, C. E. Long, and C. B. Hall. 1997. Severity of respiratory syncytial virus infection is related to virus strain. J. Infect. Dis. 175:814-820.
22. Weltzin, R., S. A. Hsu, E. S. Mittler, K. Georgakopoulos, and T. P. Monath. 1994. Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice. Antimicrob. Agents Chemother. 38:2785-2791.
23. West, W. H. L., G. R. Lounsbach, C. Bourgeois, J. W. Robinson, M. J. Carter, S. Crompton, N. Duhinden, and G. L. Toms. 1994. Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus. J. Gen. Virol. 75:2813-2819.
24. Williams, W. V., D. A. Moss, T. Kieber-Emmons, J. A. Cohen, J. N. Myers, D. B. Weiner, and M. I. Greene. 1989. Development of biologically active peptides based on antibody structures. Proc. Natl. Acad. Sci. USA 86:5537-5541.
25. Zalipsky, S., F. Albericio, and G. Barany. 1985. Preparation and use of an aminoethyl polyethylene glycol-crosslinked polystyrene graft resin support for solid-phase peptide synthesis, p. 257-260. In V. J. Hruby, C. N. Deber, and K. D. Kopple (ed.), Peptides: structure and function. Proceedings of the Ninth American Peptide Symposium. Pierce Chemical Co., Rockford, Ill.